- Home
- products
- usa pennsylvania
- genomics redefines the boundaries of fungal genomics
Show results for
Refine by
Genomics Redefines The Boundaries Of Fungal Genomics Equipment Supplied In Usa Pennsylvania
10 equipment items found
Manufactured by:Chimeron Bio based inPhiladelphia, PENNSYLVANIA (USA)
Chimeron Bio has developed a novel nanoparticle technology called “ChaESAR” – Chimera Encased Self Amplifying RNA – that harness the properties of self-amplifying RNA and synthetic genomics to engineer novel RNA drugs. This unique particle lets us encase and protect the mRNA and deliver to various ...
Manufactured by:Chimeron Bio based inPhiladelphia, PENNSYLVANIA (USA)
Self-amplifying RNA (saRNA) replicon is a type of RNA genome that is unique to certain families of viruses. This highly specialized system lets the virus make multiple copies of its RNA genome, and therefore encoded proteins, from just a single RNA template. ...
Manufactured by:JBS Science Inc based inDoylestown, PENNSYLVANIA (USA)
The HBV NGS hyb panel is a hybridization capture panel intended for research of hepatitis B virus (HBV) in frozen tissue, FFPE tissue, and cell ...
Manufactured by:10x Genomics based inPleasanton, PENNSYLVANIA (USA)
Automate your single cell ...
Manufactured by:LifeAire Systems, LLC based inAllentown, PENNSYLVANIA (USA)
The Aire~HCX series in-duct modules offer the most comprehensive methodology to kill biologicals that can cause hospital acquired infections (HAIs) or subclinical infections. The systems have been genomically and mathematically modeled, and tested towards kill of the anthrax spore and the delivery of a 9-log reduction of biological ...
by:Thermo Fisher Scientific, LIMS & Laboratory Software based inPhiladelphia, PENNSYLVANIA (USA)
Expand your research to cover 2M to 130M sequencing reads per run with this scalable platform. The Ion GeneStudio S5 systems are designed to enable a broad range of targeted next-generation sequencing (NGS) applications with speed and scalability. Five Ion S5 chips enable a sequencing throughput range of 2M to 130M reads per ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Our DecisionDx-UMSeq is a 7-gene test that uses next-generation sequencing (NGS) to identify somatic mutations relevant to uveal melanoma. Researchers believe that identifying mutations in tumor genes may someday help guide treatment decisions. Because the amount of tumor biopsy tissue is limited, it is important to gain as much information as possible about a uveal melanoma tumor from a single ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Metastasis: DecisionDx-SCC is now commercially available. DecisionDx-SCC is clinically validated as a significant predictor of metastasis and the strongest predictor of risk compared to traditional clinical and pathological factors. DecisionDx-SCC complements traditional prognostic risk assessment factors, enabling more informed choices about treatment and follow-up ...
by:Castle Biosciences, Inc. based inFriendswood, TEXAS (USA)
Predicting Individual Risk of Recurrence or Metastasis: DecisionDx-Melanoma was designed to address the need for a more accurate predictor of metastatic risk in patients diagnosed with cutaneous (skin) melanoma. ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the presence or absence of bladder cancer1, and comes as a suite of three product variations, each optimised for a different point in the patient ...